中文字幕久久不卡_国产成人二三视频_在线亚洲欧美久草_久久人人超碰九七_亚洲无码欧洲色图

159-2642-3062 027-65317797
服務(wù)熱線(工作日:9:00-17:30)

瀏覽量: 537

  • 產(chǎn)品名稱: Research Grade Bevacizumab ( 貝伐珠單抗 )
  • 產(chǎn)品貨號(hào): CSD00004
  • 貨期: 現(xiàn)貨
  • 價(jià)格與訂購: 2480
  • 數(shù)量:
    庫存: 100
  • 規(guī)格: 100μg
  • 產(chǎn)品信息
  • 如何訂購
    貨號(hào)(Catalog No.)
    CSD00004
    通用名INN
    Bevacizumab
    純度(Purity)
    >95%
    濃度( Concentration)
    1mg/ml
    Formulation
    PBS buffer PH7.5
    Source
    CHO cells
    內(nèi)毒素(Endotoxin level)
    Please contact with the lab for this information.
    產(chǎn)品描述(Description)
    Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab, a humanized monoclonal antibody,specifically binds to all VEGF-A isoforms with high affinity.
    別名(Alternative names)
    12-IgG1,F(ab)-12 IgG1,Fab-12 IgG1,rhuMAb-VEGF
    靶點(diǎn);物種(Specificity target name;species)
    VEGFA[Homo sapiens]
    活性研究(體外/體內(nèi)研究)(Activity in vitro)
    Bevacizumab, a humanized monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity, and inhibits its interaction with VEGFR-1 and VEGFR-2. Experimental analysis shows that the EC50 of Bevacizumab to bind VEGF analyzed by ELISA is 0.18 μg/mL. Binding kinetics assays show similar results that Bevacizumab inhibits the VEGF-induced proliferation of HUVEC with an IC50 value of 0.047±0.0081 μg/mL.
    受體鑒定(Receptor identification)
    IgG1-kappa
    分子量(MV)
    149000.00 Da 
    CAS
    216974-75-3
    存儲(chǔ)條件(Storage)
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Store at +4°C short term (1-2 weeks).
    Store at -20 °C 12 months.
    Store at -80°C long term.
    Note
    For research use only .
吴川市| 铅山县| 阿荣旗| 保康县| 大厂| 西盟| 营山县| 志丹县| 民乐县| 普兰县| 历史| 祁阳县| 上饶县| 浮梁县| 宝丰县| 乌拉特后旗| 慈利县| 安义县| 冕宁县| 奉化市| 观塘区| 合阳县| 南漳县| 古田县| 同德县| 邯郸县| 东城区| 茂名市| 荆门市| 廊坊市| 海南省| 曲麻莱县| 伊宁县| 静海县| 云阳县| 朔州市| 长丰县| 鄂州市| 岳池县| 泽普县| 山东省|